World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
22251
World Ranking
12390
National Ranking
670

Overview

Dirk Reinhardt is affiliated with the University of Duisburg-Essen in Germany and has a research focus spanning medicine and biochemistry, genetics, and molecular biology. Their extensive work covers various subfields including hematology, molecular biology, public health, environmental and occupational health, pediatrics, perinatology and child health, and cancer research.

Their research topics prominently feature acute myeloid leukemia, acute lymphoblastic leukemia, childhood cancer survivors' quality of life, hematopoietic stem cell transplantation, chronic myeloid leukemia treatments, cancer genomics and diagnostics, and extracellular vesicles in disease.

Recent publications by Dirk Reinhardt include:

  • The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets, 2021, Cancer Discovery
  • DNA in extracellular vesicles: from evolution to its current application in health and disease, 2022, Cell & Bioscience
  • Pediatric Acute Myeloid Leukemia-Past, Present, and Future, 2022, Journal of Clinical Medicine
  • Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COG, 2021, Cancers
  • Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial, 2022, Leukemia

Frequent co-authors collaborating with Reinhardt include:

  • Nils von Neuhoff
  • Franco Locatelli
  • Evangelia Antoniou
  • Jan-Henning Klusmann
  • Katharina Waack

Reinhardt's contributions are published primarily in journals such as:

  • Blood
  • Cancers
  • Klinische Pädiatrie
  • MMW - Fortschritte der Medizin
  • HemaSphere

The range of their research outputs demonstrates engagement with both clinical and molecular perspectives on hematological malignancies, especially in pediatric oncology contexts. Their work on precision oncology registries and therapeutic agents relates closely to improving outcomes for high-risk pediatric cancer patients.

Best Publications

  • Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.

    Ursula Creutzig;Marry M. van den Heuvel-Eibrink;Brenda Gibson;Michael N. Dworzak

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Clinical implications of FLT3 mutations in pediatric AML

    Soheil Meshinchi;Todd A. Alonzo;Derek L. Stirewalt;Michel Zwaan

  • Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

    C. Michel Zwaan;Edward A. Kolb;Dirk Reinhardt;Jonas Abrahamsson

  • The genetic basis and cell of origin of mixed phenotype acute leukaemia

    Thomas B. Alexander;Thomas B. Alexander;Zhaohui Gu;Ilaria Iacobucci;Kirsten Dickerson

  • NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

    Iris H.I.M. Hollink;Marry M. van den Heuvel-Eibrink;Susan T.C.J.M. Arentsen-Peters;Marta Pratcorona

  • Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.

    Ursula Creutzig;M. Zimmermann;J. Ritter;D. Reinhardt

  • Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study

    Barbara C. Worst;Barbara C. Worst;Cornelis M. van Tilburg;Gnana Prakash Balasubramanian;Petra Fiesel;Petra Fiesel

  • Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98

    Ursula Creutzig;Martin Zimmermann;Dirk Reinhardt;Michael Dworzak

  • Treatment and prognostic impact of transient leukemia in neonates with Down syndrome

    Jan-Henning Klusmann;Ursula Creutzig;Martin Zimmermann;Michael Dworzak

  • Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia

    B F Goemans;Ch M Zwaan;Ch M Zwaan;M Miller;M Zimmermann

  • Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98

    Christine von Neuhoff;Dirk Reinhardt;Annette Sander;Martin Zimmermann

  • FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.

    Christian M Zwaan;Soheil Meshinchi;Jerald P Radich;Anjo J P Veerman

  • Childhood cancer predisposition syndromes : A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology

    Tim Ripperger;Stefan S. Bielack;Arndt Borkhardt;Ines B. Brecht;Ines B. Brecht

  • Improved Treatment Results in High-Risk Pediatric Acute Myeloid Leukemia Patients After Intensification With High-Dose Cytarabine and Mitoxantrone: Results of Study Acute Myeloid Leukemia–Berlin-Frankfurt-Münster 93

    U Creutzig;J Ritter;M Zimmermann;D Reinhardt

  • miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia

    Jan-Henning Klusmann;Zhe Li;Katarina Böhmer;Aliaksandra Maroz

  • Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.

    T Lehrnbecher;D Varwig;J Kaiser;D Reinhardt

  • Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

    Gertjan J. L. Kaspers;Martin Zimmermann;Dirk Reinhardt;Brenda E. S. Gibson

  • Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML-BFM 98

    Ursula Creutzig;Martin Zimmermann;Thomas Lehrnbecher;Norbert Graf

  • AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

    U Creutzig;D Reinhardt;S Diekamp;M Dworzak

Frequent Co-Authors

Martin Zimmermann
Martin Zimmermann Hannover Medical School
Michael Dworzak
Michael Dworzak Medical University of Vienna
Marry M. van den Heuvel-Eibrink
Marry M. van den Heuvel-Eibrink University Medical Center Utrecht
Rob Pieters
Rob Pieters Princess Máxima Center
André Baruchel
André Baruchel Hôpital Robert-Debré
Henrik Hasle
Henrik Hasle Aarhus University Hospital
Thomas Lehrnbecher
Thomas Lehrnbecher Goethe University Frankfurt
Jan Trka
Jan Trka Charles University
Todd A. Alonzo
Todd A. Alonzo University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open new career pathways in the healthcare field, especially if you’re interested in medicine but seeking alternative or flexible educational options. Accredited online programs are now available for many in-demand healthcare roles, offering convenience along with affordability.

One option is pursuing a him degree online, which prepares graduates for careers handling medical data and digital health information. Those interested in administrative support might consider medical coding certification programs. Both fields are essential for the smooth operation of healthcare institutions.

For those who want to provide direct patient care, online nurse practitioner programs can lead to advanced practice roles and greater responsibility. It’s also important to consider how much does online nursing school cost to make informed decisions about your education investment.

By comparing curriculum details, tuition costs, and certification pathways, you can choose an online degree that aligns with your professional goals in the ever-evolving world of healthcare.

Best Scientists Citing Dirk Reinhardt

Trending Scientists

Recently Published Articles